Gene Logic Inc. Recruits Pharmaceutical Executive as Senior Vice President of Clinical Development

GAITHERSBURG, Md.--(BUSINESS WIRE)--Gene Logic Inc. (NASDAQ:GLGC) announced today the appointment of Stephen R. Donahue, M.D. as Senior Vice President of Clinical Development. Dr. Donahue will lead the Company’s efforts in clinical development to advance proprietary drug candidates it acquires through drug repositioning partnerships. Dr. Donahue’s responsibilities will integrate with those of Gene Logic’s Rediscovery and Business Development and Licensing groups to drive the growth of the Company’s emerging business in Drug Repositioning.

MORE ON THIS TOPIC